RCM
DTIL icon

RA Capital Management’s Precision BioSciences DTIL Stock Holding History

RA Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-61,412
Closed -$15.5M – 35
2019
Q3 		$15.5M Hold
61,412
– – 0.92% 21
2019
Q2 		$24.4M Hold
61,412
– – 1.31% 19
2019
Q1 		$33.1M Buy
+61,412
New +$32.6M 1.43% 21

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
ACWM
Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

RA Capital Management's DTIL Position: Q4 2019 in Review

RA Capital Management sold out of Precision BioSciences (DTIL) in Q4 2019, closing a stake of 61,412 shares — an estimated $15.5M sold.

RA Capital Management first reported a position in DTIL in Q1 2019 and held it in 3 quarters. The position peaked at $33.1M in Q1 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q4 2019.

  • RA Capital Management reported no remaining Precision BioSciences position as of Q4 2019 after selling out during the quarter.
  • RA Capital Management sold 61,412 Precision BioSciences shares in Q4 2019, an estimated $15.5M.
  • RA Capital Management first reported a position in Precision BioSciences in Q1 2019 and held it in 3 quarters.
  • RA Capital Management's Precision BioSciences position peaked at $33.1M in Q1 2019.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2019.

Based on RA Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.